Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional study Public Deposited

Downloadable Content

Download PDF
Creator
  • Hu, Fengyu
    • Other Affiliation: Guangzhou Eighth People’s Hospital, Guangzhou, China
  • Morano, Jamie P
    • Other Affiliation: University of South Florida, Morsani College of Medicine, USF International, Tampa, USA
  • Wang, Charles
    • Affiliation: School of Medicine, Division of Infectious Diseases, Department of Medicine
    • Other Affiliation: UNC-Project – China, Department of Medicine, Division of Gastroenterology Providence, Brown University School of Medicine, Rhode Island, USA
  • Tucker, Joseph
    • Affiliation: School of Medicine, Division of Infectious Diseases, Department of Medicine
    • Other Affiliation: UNC-Project – China, Guangzhou Eighth People’s Hospital, Guangzhou, China
  • Lan, Yun
    • Other Affiliation: Guangzhou Eighth People’s Hospital, Guangzhou, China
  • Xu, Min
    • Other Affiliation: Guangzhou Eighth People’s Hospital, Guangzhou, China
  • Cai, Weiping
    • Other Affiliation: Guangzhou Eighth People’s Hospital, Guangzhou, China
  • Zhou, Kali
    • Other Affiliation: Guangzhou Eighth People’s Hospital, Guangzhou, China
  • Lemon, Stanley
    • Affiliation: School of Medicine, Division of Infectious Diseases, Department of Medicine
    • Other Affiliation: UNC-Project – China
Abstract
  • Abstract Background End-stage liver disease and hepatocellular carcinoma due to hepatitis C virus (HCV) co-infection are increasingly common causes of death among HIV-infected individuals. However, there are few clinical investigations of HIV/HCV co-infected individuals from low and middle-income nations. Here, we compare the epidemiology of HCV-infected and HIV/HCV co-infected individuals in Southern China and examine hepatic fibrosis scores in co-infected individuals. Methods We conducted a retrospective cross-sectional study of treatment-naïve HIV/HCV co-infected and HCV mono-infected subjects. Bivariate and multivariate models were used to examine the association between demographics and HCV genotype. Among co-infected individuals, we also studied the relationship between fibrosis scores derived from non-invasive studies and HCV genotype. Results Data were collected from 175 HCV-infected individuals, including 89 (51 %) HIV/HCV co-infected individuals. HIV/HCV co-infection was correlated with intravenous drug use (AOR 46.25, p < 0.001) and not completing high school (AOR 17.39, p < 0.001) in a multivariate model. HIV/HCV co-infected individuals were more likely to be infected with HCV genotype 6a (p < 0.0001) or 3a (p < 0.023), whereas increased fibrosis (FIB-4 score) was associated with HCV genotype 3a infection (β 2.18, p < 0.001). Discussion Our results suggest that intravenous drug use is driving HIV/HCV co-infection in Southern China. While additional studies are needed, HCV genotype 6a is more common and genotype 3a appears to be associated with more severe hepatic fibrosis in co-infected individuals. Conclusions Future HIV/HCV co-infection research in China should focus on at risk populations, HCV testing uptake, and genotype-specific treatment.
Date of publication
Identifier
  • doi:10.1186/s12879-015-1135-1
Resource type
  • Article
Rights statement
  • In Copyright
Rights holder
  • Zhou et al.
Language
  • English
Bibliographic citation
  • BMC Infectious Diseases. 2015 Sep 30;15(1):401
Publisher
  • BioMed Central
Parents:

This work has no parents.

Items